Agios Pharma (AGIO) Misses Q4 EPS by 8c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.41), $0.08 worse than the analyst estimate of ($1.33). Revenue for the quarter came in at $44 million versus the consensus estimate of $40.17 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• BIG3 Basketball to go public via Graf Global merger at $290 million